Skip to main content
Back to Andreessen Horowitz

Andreessen Horowitz's Therapeutics Portfolio

Browse 13 Therapeutics companies funded by Andreessen Horowitz. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
13
Total Funding in Therapeutics
$946.1M

Therapeutics Portfolio Companies (13)

Export
BiotechnologyLife ScienceTherapeutics

Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives.

San Francisco, United States
July 2022
$65.0M
Series A

Founder Contacts

30,000+ verified contacts

Health CareInformation TechnologyInsuranceMental HealthTherapeutics

Headway builds a mental healthcare system that enables therapists to accept insurance and scale their practices.

New York, United States
July 2024
$100.0M
Series D

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMedicalTherapeutics

BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.

San Mateo, United States
July 2022
$75.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

Alameda, United States
June 2026
$25.0M
Grant

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceOncologyTherapeutics

Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.

South San Francisco, United States
May 2026
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Health CareMedicalTherapeuticsWellness

Omada Health is a digital behavioral medicine company that helps members change their mindsets to improve health and build lasting change.

San Francisco, United States
May 2025
Secondary Market

Founder Contacts

30,000+ verified contacts

Alternative MedicineBiotechnologyLife ScienceTherapeutics

Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.

Cambridge, United States
April 2023
$270.0M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyGeneticsTherapeutics

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

South San Francisco, United States
April 2026
$150.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Ventus Therapeutics develops small molecule drugs that target autoimmune diseases, inflammatory diseases, and cancer.

Waltham, United States
April 2023
$150K
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsOncologyPrecision MedicineTherapeutics

Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform.

San Diego, United States
April 2023
$28.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Arda is taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions.

San Francisco, United States
October 2024
$43.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.

Boston, United States
September 2024
$65.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.

Alameda, United States
June 2024
$125.0M
Series B

Founder Contacts

30,000+ verified contacts

Explore Andreessen Horowitz's Full Portfolio

View all companies funded by Andreessen Horowitz across every industry and funding stage.

View Full Andreessen Horowitz Portfolio